Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2019
SIETES contiene 92806 citas

 
 
 1 a 20 de 583 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Rilpivirine et HIV chez les adolescents. Prescrire 2017;37:13-4. [Ref.ID 101362]
2. Cita con resumen
Anónimo. Elvitegravir (Vitekta) for HIV. Med Lett Drugs Ther 2016;58:10-1. [Ref.ID 100789]
3.Enlace a cita original
Günthard HF, Saag MS, Benson CA, Del Río C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society - USA Panel. JAMA 2016;316:191-210. [Ref.ID 100629]
5.Enlace a cita original Cita con resumen
Wyles DL, Ruane PJ, Sulkowski MS, Dieterich D, Luetkemeyer A, Morgan TR, Sherman KE, Dretler R, Fishbein D, Gathe JC, Henn S, Hinestrosa F, Huynh C, McDonald C, Mills A, Overton ET, Ramgopal M, Rashbaum B, Ray G, Scarsella A, Yozviak J, McPhee F, Liu Z, Hughes E, Yin PD, Noviello S, Ackerman P, for the ALLY-2 Investigators. Daclastavir plus sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med 2015;373:714-25. [Ref.ID 99507]
6.Enlace a cita original Cita con resumen
Naggie S, Cooper C, Saag M, Workowski K, Towner WJ, Marks K, Luetkemeyer A, Baden RP, Sax PE, Gane E, Santana-Bagur J, Stamm LM, Yang JC, German P, Dvory-Sobol H, Ni L, Pang PS, McHutchison JG, Stedman CAM, Morales-Ramirez JO, Bräu N, Jayaweera D, Colson AE, Tebas P, Wong DK, Dieterich D, Sulkowski M, for the ION-4 Investigators. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med 2015;373:705-13. [Ref.ID 99506]
7. Cita con resumen
Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S, GS-US-292-0104/0111 Study Team. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. Lancet 2015;385:2606-15. [Ref.ID 99315]
8. Cita con resumen
Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne KM, Napoli A, Hardin WR, Ribaudo HJ. Vitamin D and calcium attenuate bone loss with antiretroviral therapy initiation: a randomized trial. Ann Intern Med 2015;162:815-24. [Ref.ID 99296]
9.Tiene citas relacionadas Cita con resumen
Molina J-M, Orkin C, Iser DM, Zamora F-X, Nelson M, Stephan C, Massetto B, Gaggar A, Ni L, Svarovskaia E, Brainard D, Subramanian GM, McHutchison JG, Puoti M, Rockstroh JK, for the PHOTON-2 study team. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Lancet 2015;385:1098-106. [Ref.ID 98986]
10.Tiene citas relacionadas
Naggie S, Kim AY. PHOTON-2: hope for patients with HIV and HCV co-infection?. Lancet 2015;385:1052-4. [Ref.ID 98982]
11. Cita con resumen
Anónimo. Metreleptin (Myalept) - A leptin analog for generalized lipodystrophy. Med Lett Drugs Ther 2015;57:13-4. [Ref.ID 98829]
12.Enlace a cita original
Tseng A, Seet J, Phillips EJ. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol 2015;79:182-94. [Ref.ID 98779]
13. Cita con resumen
Raffi F, Babiker AG, Richert L, Molina J-M, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy J-F, Vella S, Chêne G, Pozniak A, for the NEAT001/ANRS143 Study Group. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet 2014;384:1942-51. [Ref.ID 98452]
14. Cita con resumen
Anónimo. Etravirine et HIV chez les enfants de plus de 6 ans. Prescrire 2014;34:416. [Ref.ID 97946]
15. Cita con resumen
Anónimo. Dolutégravir. Prescrire 2014;34:414-5. [Ref.ID 97945]
16. Cita con resumen
Anónimo. Raltégravir et HIV chez les enfants de plus de 2 ans. Prescrire 2014;34:413. [Ref.ID 97944]
17. Cita con resumen
Rangaka MX, Wilkinson RJ, Boulle A, Glynn JR, Fielding K, Van Cutsem G, Wilkinson KA, Goliath R, Mathee S, Goemaere E, Maartens G. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet 2014;384:682-90. [Ref.ID 97896]
18. Cita con resumen
Sulkowski MS, Naggie S, Fessel WJ, Mounzer K, Shuhart M, Luetkemeyer AF, Gaggar A, Ni L, Svanovskaia E, Brainard DM, Symonds WT, Subramanian M, McHutchison JG, Rodríguez-Torres M, Dieterich D, for the PHOTON-1 Investigators. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA 2014;212:353-61. [Ref.ID 97822]
19. Cita con resumen
Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 2014;384:258-71. [Ref.ID 97821]
20. Cita con resumen
Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbel TB, Sax PE, Gulick RM, O'Keefe L, Robertson KR, Tierney C. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med 2014;161:1-10. [Ref.ID 97795]
Seleccionar todas
 
 1 a 20 de 583 siguiente >>